Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2020 Results Earnings Conference Call March 4, 2021 8:00 AM ET Â Company Participants Christi Waarich - Director, Investor Relations and Corporate Communications Robert Gould - President & CEO Bryan Stuart - Chief Operating Officer Chris Moxham - Chief Scientific Officer Peter Thomson - Vice President, Finance and Accounting Conference Call Participants Ted Tenthoff - Piper Sandler Joseph Schwartz - SVB Leerink Dae Gon Ha - Stifel Matthew Harrison - Morgan Stanley ...